乐
乐观
乐观 · 25%OSCR
$20.09
情景价格
$31.890
-1.505 (-4.72%)收盘时
Loading chart…
- 最高
- 33.505
- 开盘
- 33.380
- 成交量加权均价
- 32.35
- 成交量
- 5.75M
- 市值
- 4.19B
- 最低
- 31.650
- 成交额
- 186.16M
- 企业价值/息税折旧摊销前利润（TTM）
- 3.97
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.
AI 分析 of Oscar Health Inc (OSCR)
买入Oscar Health Inc is a good buy right now, trading at $31.89 with a forward P/E of 588.24, suggesting that while current earnings are high, future growth expectations are significant. The company has shown strong revenue growth, with Q1 2026 revenue at $4.65 billion, and a positive net income of $679 million in the same quarter. However, the RSI of 38.04 indicates that the stock is currently oversold, presenting a buying opportunity.
估值指标
Oscar Health Inc（OSCR）当前预期市盈率为 588.24，5 年平均预期市盈率为 124.24。
Alphio AI 对 OSCR 的价格情景
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。
持有 OSCR 的大户
事件时间线
资讯
9.510-12NewsfilterOscar Health to Release Q3 2026 Financial Results on November 5
2.009-30FoolInvestors Overlook Healthcare Sector Amid AI Focus
5.009-25FoolFour Overlooked Stocks with Doubling Potential
- 8.509-19Newsfilter
Oscar Health Share Distribution of 6.3 Million Shares by Thrive Capital
2.009-12Yahoo FinanceHealthcare Stocks Surge Amid Macroeconomic Uncertainty
OSCR 常见问题 —— 由 Alphio AI 解答
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Oscar Health Inc is a good buy right now, trading at $31.89 with a forward P/E of 588.24, suggesting that while current earnings are high, future growth expectations are significant. The company has shown strong revenue growth, with Q1 2026 revenue at $4.65 billion, and a positive net income of $679 million in the same quarter. However, the RSI of 38.04 indicates that the stock is currently oversold, presenting a buying opportunity.
社区
更多 ↗
$oscr is finishing up a 5 year IPO base. In 2021 they did $1.84B in revenue. This year they will do 10X. You missed nothing. This is the beginning
展开
$OSCR CMS has cracked down on unauthorized enrollments after tracking a surge in consumer complaints, analyzing statistically implausible application rates submitted by specific brokers, and reviewing accounts missing critical identifying information like Social Security numbers. They have canceled approximately 315,000 unauthorized enrollments covering more than 760,000 individuals, which is expected to result in a return of roughly $2.2B in taxpayer-funded subsidies. Oscar Health accounted for >250,000 of these enrollments!
展开
$OSCR Management grew and sold Aethna to CVS and shareholders did great. Can there be a repeat? Sometimes they rhyme. If there is a solution for healthcare, OSCR might have the answers. Look at the base since the IPO. You haven't missed a thing. We might be at the point where the meat of the move begins ahead.
展开
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。